Cytosorbents (CTSO) Market Capitalization (2010 - 2026)

Cytosorbents (CTSO) has reported Market Capitalization for 17 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 70.99% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (down 70.99% YoY), and the FY2025 full-year result was $2.0 million, down 19.44% from the prior year.
• Market Capitalization retreated to $1.2 million in Q2 2026 per CTSO's latest filing, from $1.8 million in the prior quarter.
• Across five years, Market Capitalization topped out at $7.9 million in Q2 2023 and bottomed at $1.2 million in Q2 2026.
• Historically, Market Capitalization has averaged $3.7 million across 5 years, with a median of $3.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization sank 83.19% in 2022, then jumped 110.82% in 2025.
• Over 5 years, Market Capitalization stood at $3.4 million in 2022, then fell by 26.71% to $2.5 million in 2023, then rose by 0.66% to $2.5 million in 2024, then slipped by 19.44% to $2.0 million in 2025, then slumped by 42.15% to $1.2 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $1.2 million, $1.8 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.